ALEXIA MUNTER: Open Payments
NPI 1407384902 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,199 in 63 payments from 16 companies in 2025. Trend: 2023 $1,107 · 2024 $1,712 · 2025 $1,199
Food & beverage: $1,199
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $238 |
| GlaxoSmithKline, LLC. | 12 | $212 |
| Regeneron Healthcare Solutions, Inc. | 8 | $178 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $98 |
| Novartis Pharmaceuticals Corporation | 4 | $81 |
| Genentech USA, Inc. | 4 | $75 |
| GENZYME CORPORATION | 3 | $60 |
| Grifols USA, LLC | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Optinose US, Inc. | 2 | $33 |
Products named: DUPIXENT, TRELEGY ELLIPTA, NEFFY, AIRSUPRA, NUCALA, Xolair, Xembify, TEZSPIRE.
Industry payments across MO — which companies pay providers there.
